Clinical Cardiovascular Adverse Events Reported Post-COVID-19 Vaccination: Are They a Real Risk?
- 10 December 2021
- journal article
- review article
- Published by Elsevier in Current Problems in Cardiology
- Vol. 47 (3) , 101077
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Takotsubo cardiomyopathy after anti-influenza vaccination: catecholaminergic effects of immune systemThe American Journal of Emergency Medicine, 2013
- Sex and Gender Differences in Myocarditis and Dilated CardiomyopathyCurrent Problems in Cardiology, 2013
- MyocarditisThe Lancet, 2012
- Myopericarditis: Etiology, management, and prognosisInternational Journal of Cardiology, 2008
- Amino acids 1 to 422 of the spike protein of SARS associated coronavirus are required for induction of cyclooxygenase-2Virus Genes, 2006
- Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT AntibodiesArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed plateletsProceedings of the National Academy of Sciences, 2002
- Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with womenEuropean Journal of Endocrinology, 2000
- Prevalence, Age Distribution, and Gender of Patients With Atrial FibrillationArchives of internal medicine (1960), 1995
- Fatal myocarditis following smallpox vaccinationAmerican Heart Journal, 1957